128 related articles for article (PubMed ID: 34983154)
1. A New Prognostic Index in Young Breast Cancer Patients.
Demir H; Demirci A; Eren SK; Beypinar I; Davarcı SE; Baykara M
J Coll Physicians Surg Pak; 2022 Jan; 32(1):86-91. PubMed ID: 34983154
[TBL] [Abstract][Full Text] [Related]
2. Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer.
Kayar R; Bastug Y; Tokuc E; Topaktas R; Akyurek EA; Kayar K; Artuk I; Ozturk M
Int Urol Nephrol; 2024 Feb; 56(2):509-518. PubMed ID: 37773579
[TBL] [Abstract][Full Text] [Related]
3. Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.
Li F; Wang Y; Dou H; Chen X; Wang J; Xiao M
Front Oncol; 2024; 14():1349021. PubMed ID: 38380360
[TBL] [Abstract][Full Text] [Related]
4. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Fucà G; Guarini V; Antoniotti C; Morano F; Moretto R; Corallo S; Marmorino F; Lonardi S; Rimassa L; Sartore-Bianchi A; Borelli B; Tampellini M; Bustreo S; Claravezza M; Boccaccino A; Murialdo R; Zaniboni A; Tomasello G; Loupakis F; Adamo V; Tonini G; Cortesi E; de Braud F; Cremolini C; Pietrantonio F
Br J Cancer; 2020 Aug; 123(3):403-409. PubMed ID: 32424148
[TBL] [Abstract][Full Text] [Related]
5. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Corti F; Lonardi S; Intini R; Salati M; Fenocchio E; Belli C; Borelli B; Brambilla M; Prete AA; Quarà V; Antista M; Fassan M; Morano F; Spallanzani A; Ambrosini M; Curigliano G; de Braud F; Zagonel V; Fucà G; Pietrantonio F
Eur J Cancer; 2021 Jun; 150():155-167. PubMed ID: 33901794
[TBL] [Abstract][Full Text] [Related]
6. PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients.
Zeng R; Liu F; Fang C; Yang J; Luo L; Yue P; Gao B; Dong Y; Xiang Y
Front Immunol; 2021; 12():724443. PubMed ID: 34777341
[TBL] [Abstract][Full Text] [Related]
7. The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery.
Sato S; Shimizu T; Ishizuka M; Suda K; Shibuya N; Hachiya H; Iso Y; Takagi K; Aoki T; Kubota K
Surg Today; 2022 Aug; 52(8):1160-1169. PubMed ID: 35015151
[TBL] [Abstract][Full Text] [Related]
8. Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer.
Lin F; Zhang LP; Xie SY; Huang HY; Chen XY; Jiang TC; Guo L; Lin HX
Front Oncol; 2022; 12():830138. PubMed ID: 35494034
[TBL] [Abstract][Full Text] [Related]
9. Pan-Immune-Inflammation Index as a Biomarker for Rheumatoid Arthritis Progression and Diagnosis.
Tutan D; Doğan AG
Cureus; 2023 Oct; 15(10):e46609. PubMed ID: 37808603
[TBL] [Abstract][Full Text] [Related]
10. A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.
Kucuk A; Topkan E; Ozkan EE; Ozturk D; Pehlivan B; Selek U
Int J Immunopathol Pharmacol; 2023; 37():3946320231187759. PubMed ID: 37404137
[No Abstract] [Full Text] [Related]
11. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
Topkan E; Kucuk A; Ozkan EE; Ozturk D; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Discov Oncol; 2023 Dec; 14(1):230. PubMed ID: 38091179
[TBL] [Abstract][Full Text] [Related]
12. The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Provenzano L; Lobefaro R; Ligorio F; Zattarin E; Zambelli L; Sposetti C; Presti D; Montelatici G; Ficchì A; Martinetti A; Arata A; Del Vecchio M; Lauria Pantano C; Formisano B; Bianchi GV; Capri G; de Braud F; Vernieri C; Fucà G
Ther Adv Med Oncol; 2023; 15():17588359231165978. PubMed ID: 37063779
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.
Besiroglu M; Shbair AT; Yasin AI; Topcu A; Turk HM; Demir T
J Coll Physicians Surg Pak; 2021 Jan; 31(1):39-44. PubMed ID: 33546531
[TBL] [Abstract][Full Text] [Related]
15. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
Topkan E; Selek U; Kucuk A; Pehlivan B
J Inflamm Res; 2022; 15():5413-5423. PubMed ID: 36158517
[TBL] [Abstract][Full Text] [Related]
16. Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer.
Baba Y; Nakagawa S; Toihata T; Harada K; Iwatsuki M; Hayashi H; Miyamoto Y; Yoshida N; Baba H
Ann Surg Open; 2022 Mar; 3(1):e113. PubMed ID: 37600089
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and Prognosis of Patients with Testicular Germ Cell Tumors.
Olcucu MT; Karamik K; Yilmaz K; Okuducu Y; Cakir S; Ates M
J Coll Physicians Surg Pak; 2020 Oct; 30(10):1041-1046. PubMed ID: 33143824
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy.
Pérez-Martelo M; González-García A; Vidal-Ínsua Y; Blanco-Freire C; Brozos-Vázquez EM; Abdulkader-Nallib I; Álvarez-Fernández J; Lázare-Iglesias H; García-Martínez C; Betancor YZ; Sánchez-Ares M; Tubío JMC; Vázquez-Rivera F; Candamio-Folgar S; López-López R; Ruiz-Bañobre J
Sci Rep; 2022 Apr; 12(1):6893. PubMed ID: 35477740
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
20. Effect of preoperative pan-immune-inflammation value on clinical and oncologic outcomes after colorectal cancer surgery: a retrospective study.
Seo YJ; Kim KE; Jeong WK; Baek SK; Bae SU
Ann Surg Treat Res; 2024 Mar; 106(3):169-177. PubMed ID: 38435496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
